News
REGN banks on Dupixent and Eylea HD gains to offset Eylea's decline while oncology wins strengthen its diversified pipeline.
TipRanks on MSN18h
Pfizer’s New Phase 1 Study on PF-07832837: A Potential Game-Changer for Atopic Dermatitis
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a Phase 1 clinical trial titled ‘A PHASE 1, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback